Imugene now in $60m cash call for new deal
MELBOURNE: Imugene was leveraging a new cancer treatment licensing deal yesterday, asking investors for a
MELBOURNE: Imugene was leveraging a new cancer treatment licensing deal yesterday, asking investors for a